Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment
#5PRI RANKED
Most Cited Paper
in Liver Disease Diagnosis and Treatment
18 Months Post-Publication
Class of 2026
“Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment”
A research intelligence initiative by Pepkio
pri.pepkio.com
Topics
Metabolic dysfunction-associated steatotic liver disease · Metabolic dysfunction-associated steatotic liver disease · heterogeneous pathomechanisms · metabolism-based treatment · Hepatic steatosis · insulin resistance · Lipid metabolism · mitochondrial dysfunction · oxidative stress · inflammatory pathways · Fibrosis progression · metabolic syndrome · therapeutic targets · personalized medicine approaches
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Liver Disease Diagnosis and Treatment Papers, Class of 2026. https://pri.pepkio.com/top-papers/liver-disease-diagnosis-and-treatment/2026. Accessed 2026-07-24. Methodology Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459